Capricor Therapeutics Reports Third Quarter 2019 Financial Results and Provides Recent Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. NKE
8. MU
9. ACN
10. USO

Go back to Capricor Therapeutics Reports Third Quarter 2019 Financial Results and Provides Recent Corporate Update

Capricor Therapeutics (CAPR) Tops Q3 EPS by 27c

November 7, 2019 4:50 PM EST

Capricor Therapeutics (NASDAQ: CAPR) reported Q3 EPS of ($0.43), $0.27 better than the analyst estimate of ($0.70). Revenue for the quarter came in at $142.1 thousand versus the consensus estimate of $200 thousand.

As of September 30, 2019, the Companys cash, cash equivalents and marketable securities totaled approximately $6.8 million compared to approximately... More